1|Page
SOCRA CCRP EXAM AND PRACTICE EXAM NEWEST
2026/ 2027 TEST BANK| COMPLETE EXAM QUESTIONS
AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) GRADED A+
With respect to IRB/IEC membership, both the FDA and the ICH require that:
A) A majority of the members' primary area of interest is in a scientific area
B) At least one member holds a Ph.D. degree or equivalent
C) At least one member's primary area of interest is in a nonscientific area
D) A majority of the members are from or have ties to the institution of record
C) At least one member's primary area of interest is in a nonscientific area
In a non-emergency situation, under which of the following conditions, if any,
may subjects been rolled into a study prior to IRB/IEC approval?
A) The investigator provides his/her written approval
B) The study drug has an FDA approved marketing application
C) The FDA provides written approval of the IND
D) Subjects cannot be enrolled until IRB/IEC approval has been obtained
D) Subjects cannot be enrolled until IRB/IEC approval has been obtained
A subject has been enrolled on a study and was randomized to the non-
treatment arm. The protocol outlines study procedures for all subjects to be
pg. 1
,2|Page
performed within one week of enrollment. Which of the following statements
about this case is correct?
A) This subject does not need to undergo any of the study procedures since the
subject is enrolled on the non-treatment arm
B) This subject should undergo all study procedures as outlined in the protocol
C) This subject only needs to undergo the study procedures that pertain
specifically to the subject
D) This subject can undergo the study procedures whenever it is convenient
B) This subject should undergo all study procedures as outlined in the protocol
A purpose of monitoring clinical trials is to verify that:
A) The rights, safety, and well-being of human subjects are protected
B) Investigators receive adequate payment for their participation in the clinical
trial
C) The investigator has received annual reports from the sponsor
D) The regulatory agency has received all case history information of subjects
enrolled on the clinical trial
A) The rights, safety, and well-being of human subjects are protected
Which of the following is the proper way to make a correction to a CRF?
A) Completely blacken the incorrect entry and then enter the correct
information
B) Back date the corrected entry with the date of the original entry
pg. 2
,3|Page
C) Initial using the initials of the sponsor's representative who reviewed the
change
D) Add the initials of the person making the change, the date of the change, and,
if necessary, a brief explanation of the change
D) Add the initials of the person making the change, the date of the change, and,
if necessary, a brief explanation of the change
True or False:
The objective of the ICH GCP Guideline is to provide a unified standard for the
European Union (EU), Japan, and the United States to facilitate the mutual
acceptance of clinical data by the regulatory authorities in these jurisdictions.
True
The contents of a Protocol should generally contain:
A) Trial objectives and purpose
B) Assessment of efficacy
C) Data handling and record keeping
D) All of the above
E) Only A & C
D) All of the above
True or False:
pg. 3
, 4|Page
Only the principle investigator is allowed to transcribe data from the source
document to the CRF?
False
Why:
True or False:
When a short form is used for Informed Consent, the witness must sign either
the short form or the summary.
False
Why: They must sign both
Form___________ is the investigator statement.
A) 1571
B) 1572
C) 3500
D) 3500A
B) 1572
pg. 4
SOCRA CCRP EXAM AND PRACTICE EXAM NEWEST
2026/ 2027 TEST BANK| COMPLETE EXAM QUESTIONS
AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) GRADED A+
With respect to IRB/IEC membership, both the FDA and the ICH require that:
A) A majority of the members' primary area of interest is in a scientific area
B) At least one member holds a Ph.D. degree or equivalent
C) At least one member's primary area of interest is in a nonscientific area
D) A majority of the members are from or have ties to the institution of record
C) At least one member's primary area of interest is in a nonscientific area
In a non-emergency situation, under which of the following conditions, if any,
may subjects been rolled into a study prior to IRB/IEC approval?
A) The investigator provides his/her written approval
B) The study drug has an FDA approved marketing application
C) The FDA provides written approval of the IND
D) Subjects cannot be enrolled until IRB/IEC approval has been obtained
D) Subjects cannot be enrolled until IRB/IEC approval has been obtained
A subject has been enrolled on a study and was randomized to the non-
treatment arm. The protocol outlines study procedures for all subjects to be
pg. 1
,2|Page
performed within one week of enrollment. Which of the following statements
about this case is correct?
A) This subject does not need to undergo any of the study procedures since the
subject is enrolled on the non-treatment arm
B) This subject should undergo all study procedures as outlined in the protocol
C) This subject only needs to undergo the study procedures that pertain
specifically to the subject
D) This subject can undergo the study procedures whenever it is convenient
B) This subject should undergo all study procedures as outlined in the protocol
A purpose of monitoring clinical trials is to verify that:
A) The rights, safety, and well-being of human subjects are protected
B) Investigators receive adequate payment for their participation in the clinical
trial
C) The investigator has received annual reports from the sponsor
D) The regulatory agency has received all case history information of subjects
enrolled on the clinical trial
A) The rights, safety, and well-being of human subjects are protected
Which of the following is the proper way to make a correction to a CRF?
A) Completely blacken the incorrect entry and then enter the correct
information
B) Back date the corrected entry with the date of the original entry
pg. 2
,3|Page
C) Initial using the initials of the sponsor's representative who reviewed the
change
D) Add the initials of the person making the change, the date of the change, and,
if necessary, a brief explanation of the change
D) Add the initials of the person making the change, the date of the change, and,
if necessary, a brief explanation of the change
True or False:
The objective of the ICH GCP Guideline is to provide a unified standard for the
European Union (EU), Japan, and the United States to facilitate the mutual
acceptance of clinical data by the regulatory authorities in these jurisdictions.
True
The contents of a Protocol should generally contain:
A) Trial objectives and purpose
B) Assessment of efficacy
C) Data handling and record keeping
D) All of the above
E) Only A & C
D) All of the above
True or False:
pg. 3
, 4|Page
Only the principle investigator is allowed to transcribe data from the source
document to the CRF?
False
Why:
True or False:
When a short form is used for Informed Consent, the witness must sign either
the short form or the summary.
False
Why: They must sign both
Form___________ is the investigator statement.
A) 1571
B) 1572
C) 3500
D) 3500A
B) 1572
pg. 4
